Avadel Pharmaceuticals PLC Sponsored ADR Stock

$6.76

6.11% today

Nasdaq, Apr 04, 09:46 pm CET

ISIN

US05337M1045

Symbol

AVDL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts News Strategies

Avadel Pharmaceuticals PLC Sponsored ADR Stock price

$7.20

-0.78 9.77% 5Y

Nasdaq, Closing price Thu, Apr 03 2025

-0.26 3.49%

ISIN

US05337M1045

Symbol

AVDL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Key metrics

Market capitalization	$695.73m
Enterprise Value	$658.90m
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	negative
EV/Sales (TTM) EV/Sales	3.90
P/S ratio (TTM) P/S ratio	4.11
P/B ratio (TTM) P/B ratio	9.41
Revenue growth (TTM) Revenue growth	504.79%
Revenue (TTM) Revenue	$169.12m
EBIT (operating result TTM) EBIT	$-42.40m
Free Cash Flow (TTM) Free Cash Flow	$-46.26m
Cash position	$73.78m
EPS (TTM) EPS	$-0.52
P/E forward	80.20
P/S forward	2.78
EV/Sales forward	2.63
Short interest	12.10%

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Get Started for Free Today

Avadel Pharmaceuticals PLC Sponsored ADR Stock Analysis

Unlock Scores for Free

??

11 Analysts have issued a Avadel Pharmaceuticals PLC Sponsored ADR forecast:

11x Buy

100%

More details on Analyst Estimates Including Price Targets

11 Analysts have issued a Avadel Pharmaceuticals PLC Sponsored ADR forecast:

Buy

100%

Analyst Estimates with Stock Price Targets

Financial data from Avadel Pharmaceuticals PLC Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Dec '24		+/- %
Revenue	169 169	505% 505% 100%
- Direct Costs	15 15	481% 481% 9%
Gross Profit	154 154	467% 467% 91%
- Selling and Administrative Expenses	178 178	19% 19% 105%
- Research and Development Expense	15 15	15% 15% 9%
EBITDA	-40 -40	71% 71% -23%
- Depreciation and Amortization	2.68 2.68	- 2%
EBIT (Operating Income) EBIT	-42 -42	69% 69% -25%
Net Profit	-49 -49	70% 70% -29%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Avadel Pharmaceuticals PLC Sponsored ADR Stock News

Neutral

GlobeNewsWire

●

3 days ago

Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference

DUBLIN, April 01, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the 24th Annual Needham Healthcare Conference on Tuesday, April 8 at 1:30 p.m. ET.

Neutral

GlobeNewsWire

●

10 days ago

Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians

DUBLIN, March 25, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the publication of six manuscripts covering clinical management, shared decision-making and goal setting for people with narcolepsy and their clinicians in a CNS Drugs supplement titled “A New Dawn in the Manageme...

Neutral

GlobeNewsWire

●

about one month ago

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

DUBLIN, Ireland, March 05, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences: Leerink Global Biopharma Conference: Fireside chat on Wednesday, March 12 at 9:20 a.m. ET. UBS Virtual CNS Day: ...

More Avadel Pharmaceuticals PLC Sponsored ADR News

Company Profile

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

Head office	Ireland
CEO	Gregory Divis
Employees	188
Founded	2015
Website	www.avadel.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now